Most Read Articles
Jairia Dela Cruz, 14 Jan 2019
The potassium-competitive acid blocker vonoprazan demonstrates superior efficacy in the treatment of patients with erosive oesophagitis compared with the proton pump inhibitor lansoprazole, with the results of a small trial showing that the former more rapidly provides complete sustained heartburn relief during the first week of therapy.
01 Mar 2016
Bathing with 2% chlorhexidine gluconate-medicated washcloth is cost-effective for the prevention of central line-associated bloodstream infection (CLABSI), based on a systematic review and meta-analysis of four studies.
08 Jan 2019
Treatment with spironolactone has shown consistent, albeit modest, clinical effectiveness in older patients with heart failure with reduced ejection fraction (HFrEF) regardless of renal eligibility criteria used, a recent study has shown.
Rachel Soon, 12 Dec 2018

MIMS Pharmacist presents an overview of superoxide dismutase (SOD) and its role in resisting the effects of oxidative stress and aging.

Constipation reduces desmopressin efficacy in children with nocturnal enuresis

30 Dec 2018

Treatment response to desmopressin for paediatric nocturnal enuresis (NE) decreases in the presence of constipation, especially in children with severe enuresis and those prescribed with low-dose desmopressin, a study has shown.

Researchers looked at 383 patients (52.7 percent boys) with NE aged 5–15 years, among whom 54 (14 percent) presented with constipation. The majority of patients (76.0 percent) had severe enuresis, and the incidence of severe enuresis in the group of patients with constipation was higher than that in the nonconstipation group (94.4 percent vs 72.9 percent; p=0.001).

In the cohort, only 346 children completed desmopressin treatment. Complete response rate was significantly lower in the presence of constipation in the group of patients with severe enuresis. Constipation was associated with the effectiveness of desmopressin whether in monosymptomatic or nonmonosymptomatic NE.

In an analysis stratifying by dose of desmopressin, nonconstipated vs constipated patients who received 0.2 mg had significantly higher complete response rate. However, in subgroups of mild-to-moderate NE and 0.4 mg desmopressin, constipation showed no association with treatment response.

Multivariate logistic regression revealed constipation to be an independent risk factor for the efficacy of desmopressin in treating enuresis (odds ratio, 3.135; 95 percent CI, 1.185–8.295; p=0.021).

The present data suggest that complete response could be likely expected in children without constipation, researchers said. Additional studies with large sample size and are needed to verify the association between constipation and desmopressin efficacy.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacist - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Jairia Dela Cruz, 14 Jan 2019
The potassium-competitive acid blocker vonoprazan demonstrates superior efficacy in the treatment of patients with erosive oesophagitis compared with the proton pump inhibitor lansoprazole, with the results of a small trial showing that the former more rapidly provides complete sustained heartburn relief during the first week of therapy.
01 Mar 2016
Bathing with 2% chlorhexidine gluconate-medicated washcloth is cost-effective for the prevention of central line-associated bloodstream infection (CLABSI), based on a systematic review and meta-analysis of four studies.
08 Jan 2019
Treatment with spironolactone has shown consistent, albeit modest, clinical effectiveness in older patients with heart failure with reduced ejection fraction (HFrEF) regardless of renal eligibility criteria used, a recent study has shown.
Rachel Soon, 12 Dec 2018

MIMS Pharmacist presents an overview of superoxide dismutase (SOD) and its role in resisting the effects of oxidative stress and aging.